EP 1087761 A2 20010404 - USE OF SUBSTITUTED 4-BIARYLBUTYRIC AND 5-BIARYLPENTANOIC ACID DERIVATIVES FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISORDERS
Title (en)
USE OF SUBSTITUTED 4-BIARYLBUTYRIC AND 5-BIARYLPENTANOIC ACID DERIVATIVES FOR THE TREATMENT OF ACUTE NEURODEGENERATIVE DISORDERS
Title (de)
VERWENDUNG VON SUBSTITUIERTEN 4-BIARYLBUTTERSÄUREN UND 5-BIARYLPENTANSÄUREN ZUR BEHANDLUNG AKUTENEURODEGENERATIVEN KRANKHEITEN
Title (fr)
UTILISATION DE DERIVES SUBSTITUES D'ACIDES 4-BIARYLBUTYRIQUE ET 5-BIARYLPENTANOIQUE POUR LE TRAITEMENT DES MALADIES NEURODEGENERATIVES AIGUS
Publication
Application
Priority
- EP 00920435 A 20000214
- EP 0001204 W 20000214
- EP 99103723 A 19990225
Abstract (en)
[origin: EP1031349A1] Use of substituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives for the Treatment of Cerebral Diseases, pharmaceutical compositions containing them, and a process for using them. The compounds of the invention have the generalized formula (T)xA-B-D-E-CO2H wherein A is an aryl or heteroaryl rings; B is an aryl or heteroaryl ring or a bond; each T is a substituent group; x is 0, 1, or 2; the group D represents &rdurule& C=O , or <CHEM> the group E represents a two or three carbon chain bearing one to three substituent groups which are independent or are involved in ring formation, possible structures being shown in the text and claims; and each of the substituents on E is an independent substituent; and include pharmaceutically acceptable salts thereof.
IPC 1-7
A61K 31/192; A61K 31/53; A61P 25/00; A61P 25/28; A61P 9/10; C07D 253/04
IPC 8 full level
A61K 31/192 (2006.01); A61K 31/195 (2006.01); A61K 31/24 (2006.01); A61K 31/4035 (2006.01); A61K 31/423 (2006.01); A61K 31/426 (2006.01); A61K 31/437 (2006.01); A61K 31/4406 (2006.01); A61K 31/4409 (2006.01); A61K 31/502 (2006.01); A61K 31/53 (2006.01); A61P 9/10 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); C07D 253/04 (2006.01)
CPC (source: EP)
A61K 31/192 (2013.01); A61K 31/195 (2013.01); A61K 31/24 (2013.01); A61K 31/4035 (2013.01); A61K 31/423 (2013.01); A61K 31/426 (2013.01); A61K 31/437 (2013.01); A61K 31/4406 (2013.01); A61K 31/4409 (2013.01); A61K 31/502 (2013.01); A61K 31/53 (2013.01); A61P 9/10 (2017.12); A61P 25/00 (2017.12); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 0050017A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
EP 1031349 A1 20000830; AR 036976 A1 20041020; AU 4101900 A 20000914; CA 2333955 A1 20000831; EP 1087761 A2 20010404; GT 200000020 A 20010817; PE 20001431 A1 20010214; WO 0050017 A2 20000831; WO 0050017 A3 20010201
DOCDB simple family (application)
EP 99103723 A 19990225; AR P000100818 A 20000225; AU 4101900 A 20000214; CA 2333955 A 20000214; EP 0001204 W 20000214; EP 00920435 A 20000214; GT 200000020 A 20000224; PE 0001512000 A 20000224